Personnel Information

写真a

KURIMOTO RYOTA


Job title

Assistant Professor

Graduating School 【 display / non-display

  • Chiba University, Faculty of Medicine, 2009.03, Graduated

Graduate School 【 display / non-display

  • Chiba University, Graduate School, Division of Medicine, Medical Oncology, Doctor's Course, 2016.03, Completed

Campus Career 【 display / non-display

  • 2016.06
    -
    2016.07
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Systems BioMedicine, Visiting Lecturer
  • 2016.08
    -
    2017.12
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Systems BioMedicine, Project Researcher
  • 2018.01
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Systems BioMedicine, Assistant Professor
  • 2018.04
    -
    2018.10
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Systems BioMedicine, Assistant Professor
  • 2018.11
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Systems BioMedicine, Assistant Professor

External Career 【 display / non-display

  • 2009.04
    -
    2010.03
    , Trainee Resident
  • 2010.04
    -
    2011.03
    , Trainee Resident
  • 2011.04
    -
    2012.03
    , Resident
  • 2012.04
    -
    2016.03
    , Senior Resident

Research Areas 【 display / non-display

  • General medical chemistry

Qualification Acquired 【 display / non-display

  • Doctor

 

Research Theme 【 display / non-display

  • Drug resistance and EMT in lung cancer, 2012.04 - 2016.05

Published Papers & Misc 【 display / non-display

  • Mitsumura T, Ito Y, Chiba T, Matsushima T, Kurimoto R, Tanaka Y, Kato T, Uchida K, Ito T, Yamamoto K, Eishi Y, Kitagawa M, Miyazaki Y, Inase N, Asahara H. Ablation of miR-146b in mice causes hematopoietic malignancy. Blood advances. 2018.12; 2 (23): 3483-3491. ( PubMed, DOI )

  • Kurimoto R, Ebata T, Iwasawa S, Ishiwata T, Tada Y, Tatsumi K, Takiguchi Y. Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma. Oncology letters. 2017.07; 14 (1): 944-950. ( PubMed, DOI )

  • Kurimoto R, Iwasawa S, Ebata T, Ishiwata T, Tada Y, Tatsumi K, Takiguchi Y. Pirfenidone in reversion of the epithelial-to-mesenchymal transition in human lung adenocarcinoma. Oncology Letters. 2017.05; 14 (1): 944-950.

  • Emiko Sakaida, Takahiro Ebata, Shunichiro Iwasawa, Ryota Kurimoto, Sachiko Yonemori, Satoshi Ota, Yukio Nakatani, Ikuo Sekine, Yuichi Takiguchi. Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma. Internal Medicine. 2017.03; 56 (5): 567-570.

  • Sakaida Emiko, Ebata Takahiro, Iwasawa Shunichiro, Kurimoto Ryota, Yonemori Sachiko, Ota Satoshi, Nakatani Yukio, Sekine Ikuo, Takiguchi Yuichi. メルケル細胞癌に対するサルベージ療法としてのアムルビシンの潜在的活性(Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma) Internal Medicine. 2017.03; 56 (5): 567-570. ( ichushi )

display all >>

Books etc 【 display / non-display

  • Hiroki Tsutsumi, Ryota Kurimoto. Symptoms / disease classification Clinical laboratory test value Complete guide. Jihou, 2019.01 Emergency in cancer patients (including Tumor-lysis syndrome)

  • Ryota Kurimoto, Yuichi Takiguchi. Targeting Epithelial-Mesenchymal Transition and Cancer Stem Cell. 2017.01

Conference Activities & Talks 【 display / non-display

  • Ryota Kurimoto, Hiroki Tsutsumi, Maiko Inotsume, Hiroshi Asahara. New regulatory mechanism of tumor suppressor microRNA let-7s. 16thn Bone Biology Forum 2019.08.16 Makuhari, Chiba, Japan

  • Ryota Kurimoto, Hiroki Tsutsumi, Hiroshi Asahara. New regulatory mechanism of tumor suppressor microRNA let-7s (comprehensive approach for tumor suppressors in vitro) . 16th Meeting of Bone Biology Forum 2019.08.16

  • Ryota Kurimoto, Hiroki Tsutsumi, Yutaro Uchida, Hiroshi Asahara. 腫瘍抑制microRNA let-7 familyの新たな制御機構の解明. 第17回日本臨床腫瘍学会 2019.07.19

  • Hiroshi Asahara, Sho Mokuda, Yoshiaki Ito, Masafumi Inui, Ryo Nakamichi, Tomoki Chiba, Ryota Kurimoto, Takahide Matsushima. miRNAs in arthritis pathogenesis and therapy. The 24th Annual Meeting of the RNA Society 2019.06.14

  • Ryota Kurimoto, Shunichiro Iwasawa, Takahiro Ebata, Tsukasa Ishiwata, Ikuo Sekine, Yuji Tada, Koichiro Tatsumi, Shuhei Koide, Atsushi Iwama, Yuichi Takiguchi. . Alteration of drug sensitivity according to the induction and reversion of epithelial-to-mesenchymal transition (EMT) in human lung adenocarcinoma cell lines harboring an EGFR mutation.. American Association for Cancer Research Annual Meeting 2016 2016

 

Campus class subject 【 display / non-display

  • Molecular Genetics,2017 - Now

External class subject 【 display / non-display

  • Medical Oncology,Chiba University